- Home
- VALN
VALN
Valneva SE
as 05-16-2025 4:00pm EST
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
| Founded: | 2012 | Country: | France |
| Employees: | N/A | City: | N/A |
| Market Cap: | 510.7M | IPO Year: | 2021 |
| Target Price: | $15.33 | AVG Volume (30 days): | 11.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.58 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.62 - $9.50 | Next Earning Date: | 05-07-2025 |
| Revenue: | $201,099,222 | Revenue Growth: | 21.64% |
| Revenue Growth (this year): | 18.74% | Revenue Growth (next year): | 29.26% |
Latest Valneva SE News
VALN Breaking Stock News: Dive into VALN Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
High Growth Tech Stocks In Europe With Promising Potential
BioPharma Dive
5 days ago
FDA follows EMA in limiting use of Valneva shot
Pharmaceutical Technology
5 days ago
Valneva’s chikungunya vaccine use halted in older adults amid safety concerns
GlobeNewswire
5 days ago
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
BioPharma Dive
8 days ago
Eli Lilly extends Purdue alliance; EMA investigates Valneva shot
GuruFocus.com
9 days ago
Valneva SE (INRLF) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...
GlobeNewswire
9 days ago
VALNEVA Declaration of shares and voting rights: April 30, 2025
GlobeNewswire
9 days ago
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Compare VALN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VALN Valneva SE - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.